Altamira Therapeutics Issues Shareholder Letter

Highlights Company's progress to becoming a pure-play RNA business and tech strategy and penetrate the multi-billion TAMHAMILTON, BERMUDA / ACCESSWIRE / May 18, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing …